<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02456155</url>
  </required_header>
  <id_info>
    <org_study_id>110-92</org_study_id>
    <nct_id>NCT02456155</nct_id>
  </id_info>
  <brief_title>A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP</brief_title>
  <acronym>SAP</acronym>
  <official_title>Study to Compare the Placement Method of Nasal Jejunal Tube in Patients With Severe Acute Pancreatitis: Bedside Placement With Ultrasound Confirmation Versus Placement Endoscopically</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Li Gang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators assessed the utility of ultrasonography in confirming the position of nasal
      jejunal tube after bedside placement when compared with endoscopic placement in patients with
      severe acute pancreatitis.

      Primary endpoint:

      Success rate.

      Secondary Endpoint:

      Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after
      placement), Tolerance of enteral nutrition, Time to approach the target calories.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We set this randomised trial to assess the safety and utility of ultrasonography in
      confirming the position of nasal jejunal tube after bedside placement when compared with
      endoscopic placement in patients with severe acute pancreatitis.

      Primary endpoint:

      Success rate.

      Secondary Endpoint:

      Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after
      placement), Tolerance of enteral nutrition, Time to approach the target calories.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Success rate is defined as the right position of nasal jejunal tube confirmed by X-ray.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>24 hours</time_frame>
    <description>gastrointestinal perforation, gastrointestinal bleeding, tie of the tube, blocking of the tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of intra-abdominal pressure</measure>
    <time_frame>3 days</time_frame>
    <description>the intra-abdominal pressure at 1h before, 1h after and 3 days after placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of enteral nutrition</measure>
    <time_frame>3 days</time_frame>
    <description>nausea, vomiting, diarrhea, abdominal pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time interval to approach the target calories</measure>
    <time_frame>7 days</time_frame>
    <description>The exact time interval from the placement of the tube to the time that the patient can tolerate the target enteral nutrition.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bedside Placement of Nasal Jejunal Tube</condition>
  <arm_group>
    <arm_group_label>ultrasound group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>using B ultrasound as a instruction technique to place Nasal Jejunal Tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endoscope group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional methods for placing Nasal Jejunal Tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placing nasal jejunal tube with ultrasound</intervention_name>
    <description>bedside placing nasal jejunal tube with ultrasound confirmation versus placing endoscopically</description>
    <arm_group_label>ultrasound group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>placing nasal jejunal tube endoscopically</intervention_name>
    <arm_group_label>endoscope group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute pancreatitis patients who need enteral nutrition;

          -  patients in acute phase of pancreatitis (within 2 weeks from onset);

          -  the severity of pancreatitis is equal to or above moderate (according to the revised
             classification of pancreatitis).

        Exclusion Criteria:

          -  diagnosed with IAH(Intra-abdominal pressure) IV grade, abdominal compartment syndrome
             (ACS);

          -  patients who have circulatory failure;

          -  patients who have gastrointestinal bleeding;

          -  patients who have specific diseases such as chronic digestive diseases and autoimmune
             diseases;

          -  patients in pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gang Li, MD.</last_name>
    <phone>+86-025-80861655</phone>
    <email>nju8icu@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>JinLing hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ke lu, Ph.D</last_name>
      <email>kkb9832@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>May 27, 2015</last_update_submitted>
  <last_update_submitted_qc>May 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing University</investigator_affiliation>
    <investigator_full_name>Li Gang</investigator_full_name>
    <investigator_title>Jinling Hospital</investigator_title>
  </responsible_party>
  <keyword>bedside placement</keyword>
  <keyword>nasal jejunal tube</keyword>
  <keyword>ultrasound</keyword>
  <keyword>severe acute pancreatitis</keyword>
  <keyword>endoscope</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

